| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $429K | -30.6% | -44.2% |
| Cost of Revenue | $123K | -16.9% | -72.2% |
| R&D Expense | $16.8M | +2.9% | +20.5% |
| SG&A Expense | $5.8M | +14.9% | -17.4% |
| Operating Income | -$22.3M | -6.6% | -8.1% |
| Interest Expense | $15K | -31.8% | +36.4% |
| Pre-tax Income | -$22.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $234K | -65.9% | — |
| Inventory | $436K | -2.9% | — |
| Current Assets | $11.2M | -65.2% | — |
| Total Assets | $19.1M | -52.2% | — |
| Current Liabilities | $13.4M | +0.7% | — |
| Long-term Debt | $26K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$59.3M | — | — |
| Capital Expenditures | $1.6M | — | — |
| Investing Cash Flow | -$199K | — | — |
| Financing Cash Flow | -$1.8M | — | — |
| Free Cash Flow | -$60.8M | — | — |
| -5.4% |
| -1.9% |
| Income Tax | $0 | — | — |
| Net Income | -$22.2M | -6.8% | -1.8% |
| EPS (Basic) | -$0.62 | -6.9% | +42.1% |
| EPS (Diluted) | -$0.62 | -6.9% | +42.1% |
| -13.3% |
| — |
| Total Liabilities | $15.7M | -0.8% | — |
| Stockholders' Equity | $3.7M | -84.8% | +27.7% |